Growth Hormone Deficiency – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Growth Hormone Deficiency – Drugs In Development, 2024 report and make more profitable business decisions.
Growth hormone deficiency (GHD) is a rare and treatable condition that occurs when the pituitary gland does not produce enough growth hormone (GH). GH is a hormone that stimulates growth and metabolism in the body. GHD can affect children and adults, but it has different effects depending on the age of onset. Children with GHD have short stature, delayed puberty, low bone strength, and other health problems. Adults with GHD may have increased body fat, high cholesterol, low muscle mass, reduced bone density, and impaired quality of life. GHD can be caused by genetic mutations, damage to the pituitary gland or hypothalamus, infections, radiation, or unknown factors. GHD is diagnosed by measuring the levels of GH and other hormones in the blood, as well as performing stimulation tests to check the response of the pituitary gland. Treatment for GHD involves injections of synthetic GH, which can help restore normal growth and metabolism.
The Growth Hormone Deficiency drugs in development market research report provide comprehensive information on the therapeutics under development for Growth Hormone Deficiency, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Growth Hormone Deficiency and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Growth Hormone Deficiency | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 30 molecules, with 30 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Growth Hormone Deficiency therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Growth Hormone Deficiency pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Growth Hormone Deficiency treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Aerami Therapeutics IncAeterna Zentaris Inc
Ahn-Gook Pharmaceutical Co Ltd
Alteogen Inc
Arya Tina Gene Company
Ascendis Pharma AS
Bolder Biotechnology Inc
Braasch Biotech LLC
Changchun GeneScience Pharmaceutical Co Ltd
Dong-A ST Co Ltd
Entera Bio Ltd
Evive Biotech
Hanmi Pharmaceuticals Co Ltd
Hollenbeck Pharmaceuticals Inc
I-Mab
Innovare R & D SA De CV
JCR Pharmaceuticals Co Ltd
Lumos Pharma Inc
Novo Nordisk AS
OPKO Health Inc
Polus Inc
Teijin Ltd
The National Institute for Biotechnology in the Negev Ltd
VISEN Pharmaceuticals
Xiamen Amoytop Biotech Co Ltd
Zhejiang Doer Biologics Corp
Zhejiang You Nuo Jin Biological Engineering Co Ltd
Zonhon Biopharma Institute Inc
Zosano Pharma Corp
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Growth Hormone Deficiency reports